Compounded tirzepatide
Sold by AbundRX · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$149
| Medication · Tirzepatide-based care option, starting price | $149 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Tirzepatide-based care option, starting price “Programs begin at $99 for semaglutide-based care and $149 for tirzepatide-based care. Pricing is designed to be straightforward and may include provider review, care planning, follow-up support, and medication fulfillment if prescribed.” | Per month$149 | Charged today$149 |
We earn nothing from this link. AbundRX has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “You can always login to your abudantwellness.co account before your products ship to change your address, method of payment or to cancel your subscription.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from abundantwellness.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Candidate list names this company 'AbundRX' but the domain is abundantwellness.co; the site's own hero text confirms identity ('AbundRX is Proud to be LegitScript Certified'). Pricing language is hedgy throughout ('may include ... medication fulfillment if prescribed') and a banner separately advertises 'Unlock Premium Access — $99 with Fast, Free Shipping', which reads like an access fee rather than a medication price. The FAQ, however, directly ties the $99/$149 figures to the semaglutide- and tirzepatide-based care options as the starting cost of the program, not a fee that explicitly excludes medication (no 'medication billed separately' language found), so these are recorded as prices rather than a membership — but the ambiguity itself is worth flagging. No state-coverage statement found anywhere checked.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.